JP2026015426A5 - - Google Patents
Info
- Publication number
- JP2026015426A5 JP2026015426A5 JP2025189065A JP2025189065A JP2026015426A5 JP 2026015426 A5 JP2026015426 A5 JP 2026015426A5 JP 2025189065 A JP2025189065 A JP 2025189065A JP 2025189065 A JP2025189065 A JP 2025189065A JP 2026015426 A5 JP2026015426 A5 JP 2026015426A5
- Authority
- JP
- Japan
- Prior art keywords
- nanoparticles
- composition
- polymer
- use according
- polymer nanoparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1918963.8A GB201918963D0 (en) | 2019-12-20 | 2019-12-20 | Polymeric nanoparticles as vaccine adjuvants |
| GB1918963.8 | 2019-12-20 | ||
| PCT/EP2020/087456 WO2021123430A1 (en) | 2019-12-20 | 2020-12-21 | Polymeric nanoparticles as vaccine adjuvants |
| JP2022538064A JP2023507497A (ja) | 2019-12-20 | 2020-12-21 | ワクチンアジュバントとしてのポリマーナノ粒子 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538064A Division JP2023507497A (ja) | 2019-12-20 | 2020-12-21 | ワクチンアジュバントとしてのポリマーナノ粒子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026015426A JP2026015426A (ja) | 2026-01-29 |
| JP2026015426A5 true JP2026015426A5 (https=) | 2026-03-12 |
Family
ID=69322661
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538064A Pending JP2023507497A (ja) | 2019-12-20 | 2020-12-21 | ワクチンアジュバントとしてのポリマーナノ粒子 |
| JP2025189065A Pending JP2026015426A (ja) | 2019-12-20 | 2025-11-10 | ワクチンアジュバントとしてのポリマーナノ粒子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538064A Pending JP2023507497A (ja) | 2019-12-20 | 2020-12-21 | ワクチンアジュバントとしてのポリマーナノ粒子 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230218752A1 (https=) |
| EP (1) | EP4076519A1 (https=) |
| JP (2) | JP2023507497A (https=) |
| CN (1) | CN115279401A (https=) |
| AU (1) | AU2020407306A1 (https=) |
| CA (1) | CA3162350A1 (https=) |
| GB (1) | GB201918963D0 (https=) |
| WO (1) | WO2021123430A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114657210B (zh) * | 2022-03-03 | 2023-08-11 | 中山大学孙逸仙纪念医院 | 一种基于负载gsdmd蛋白n端肽段的纳米材料及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4601903A (en) | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
| JP4526708B2 (ja) | 1998-09-01 | 2010-08-18 | メリオン リサーチ スリー リミテッド | 細胞を媒介した免疫応答を誘導する方法及びそのための非経口ワクチン製剤 |
| US8021689B2 (en) * | 2006-02-21 | 2011-09-20 | Ecole Polytechnique Federale de Lausanne (“EPFL”) | Nanoparticles for immunotherapy |
| US8323696B2 (en) * | 2008-08-29 | 2012-12-04 | Ecole Polytechnique Federale De Lausanne | Nanoparticles for immunotherapy |
| JP6008345B2 (ja) | 2009-02-27 | 2016-10-19 | 東レ株式会社 | 免疫原性組成物 |
| US9572894B2 (en) | 2010-10-18 | 2017-02-21 | The University Of Iowa Research Foundation | Biodegradable particulate formulations |
| CN104338126B (zh) * | 2013-08-08 | 2018-05-04 | 中国科学院过程工程研究所 | 一种具有治疗或预防hpv病毒的疫苗组合物及其应用 |
| US10117886B2 (en) | 2014-05-30 | 2018-11-06 | Hao Cheng | Hyaluronidase and a low density second PEG layer on the surface of therapeutic-encapsulated nanoparticles to enhance nanoparticle diffusion and circulation |
| MX2018010586A (es) * | 2016-03-02 | 2019-03-28 | Univ Texas | Nanovacuna de activacion de "sting" para inmunoterapia. |
| US11925693B2 (en) * | 2017-07-27 | 2024-03-12 | The Board Of Trustees Of The Leland Stanford Junior University | Polymeric nanoparticles for enhanced cancer immunotherapy |
-
2019
- 2019-12-20 GB GBGB1918963.8A patent/GB201918963D0/en not_active Ceased
-
2020
- 2020-12-21 US US17/787,051 patent/US20230218752A1/en not_active Abandoned
- 2020-12-21 WO PCT/EP2020/087456 patent/WO2021123430A1/en not_active Ceased
- 2020-12-21 AU AU2020407306A patent/AU2020407306A1/en active Pending
- 2020-12-21 EP EP20841918.4A patent/EP4076519A1/en active Pending
- 2020-12-21 JP JP2022538064A patent/JP2023507497A/ja active Pending
- 2020-12-21 CN CN202080097299.0A patent/CN115279401A/zh active Pending
- 2020-12-21 CA CA3162350A patent/CA3162350A1/en active Pending
-
2025
- 2025-11-10 JP JP2025189065A patent/JP2026015426A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2026015426A5 (https=) | ||
| Boroumand et al. | Chitosan-based nanoparticles against viral infections | |
| Malik et al. | Trimethyl chitosan nanoparticles encapsulated protective antigen protects the mice against anthrax | |
| JP6382936B2 (ja) | ナノ粒子ベースの組成物 | |
| Vasiliev | Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation | |
| Gopi et al. | Effective drug delivery system of biopolymers based on nanomaterials and hydrogels-a review | |
| Islam et al. | Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review | |
| Rauta et al. | Parenteral immunization of PLA/PLGA nanoparticle encapsulating outer membrane protein (Omp) from Aeromonas hydrophila: Evaluation of immunostimulatory action in Labeo rohita (rohu) | |
| Zhang et al. | Potent antigen-specific immune responses stimulated by codelivery of CpG ODN and antigens in degradable microparticles | |
| JP2006526649A5 (https=) | ||
| K Garg et al. | Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers | |
| JP2010527906A5 (https=) | ||
| JP2016511747A5 (https=) | ||
| JP2012524793A (ja) | 免疫調節性生体分子を組み合わせて送達するためのヒドロゲル | |
| US20220331259A1 (en) | Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof | |
| Florindo et al. | New approach on the development of a mucosal vaccine against strangles: systemic and mucosal immune responses in a mouse model | |
| Zhang et al. | Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases | |
| Debnath et al. | Potential application of bionanoparticles to treat severe acute respiratory syndrome coronavirus-2 infection | |
| JP2018515530A5 (https=) | ||
| US9821055B2 (en) | Vaccine adjuvants | |
| Liu et al. | Development of PDA nanoparticles for H9N2 avian influenza BPP-V/BP-IV epitope peptide vaccines: immunogenicity and delivery efficiency improvement | |
| Kakehbaraei et al. | Emerging trends in viral infection inhibition using a chitosan-based drug delivery system | |
| Parmaksız et al. | Carboxymethyl chitosan for drug and vaccine delivery: an overview | |
| MuZikova et al. | Macromolecular systems for vaccine delivery | |
| Rosales-Mendoza et al. | Chitosan-based mucosal nanovaccines |